What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?

What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?

Guardado en:
Detalles Bibliográficos
Autor principal: Nicola Silvestris
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Medicine
R
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/9818b25054714dda8dc3970dda1d96f3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9818b25054714dda8dc3970dda1d96f3
record_format dspace
spelling oai:doaj.org-article:9818b25054714dda8dc3970dda1d96f32021-12-04T04:34:43ZWhat is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?2352-396410.1016/j.ebiom.2021.103733https://doaj.org/article/9818b25054714dda8dc3970dda1d96f32021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352396421005272https://doaj.org/toc/2352-3964Nicola SilvestrisElsevierarticleMedicineRMedicine (General)R5-920ENEBioMedicine, Vol 74, Iss , Pp 103733- (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Medicine (General)
R5-920
spellingShingle Medicine
R
Medicine (General)
R5-920
Nicola Silvestris
What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
format article
author Nicola Silvestris
author_facet Nicola Silvestris
author_sort Nicola Silvestris
title What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_short What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_full What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_fullStr What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_full_unstemmed What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
title_sort what is the immunological response to bnt162b2 mrna vaccine in immunocompromised patients?
publisher Elsevier
publishDate 2021
url https://doaj.org/article/9818b25054714dda8dc3970dda1d96f3
work_keys_str_mv AT nicolasilvestris whatistheimmunologicalresponsetobnt162b2mrnavaccineinimmunocompromisedpatients
_version_ 1718372984105730048

Ejemplares similares